13 14 15 2 Researches related with the application of functional lipids such as 1 polyunsaturated fatty acids (PUFAs) have been conducted in various fields with a 2 view to health and dietary requirements. Novel rich sources other than known 3 natural sources such as plant seeds and fish oils are required for increasing 4 demands of PUFAs. The filamentous fungus Mortierella alpina 1S-4 produces 5 triacylglycerols rich in arachidonic acid, i.e., ones reaching 20 g/l in concentration 6 and containing 30-70% arachidonic acid as total fatty acids. Various mutants 7 derived from M. alpina 1S-4 have led to the production of oils containing various 8 PUFAs. Molecular breeding of M. alpina strains by means of manipulation of the 9 genes involved in PUFA biosynthesis facilitates improvement of PUFA productivity 10 and elucidation of the functions of their enzymes. This review describes practical 11 PUFA production through mutant breeding, functional analyses of the genes of the 12 enzymes involved in PUFA biosynthesis, and recent advances in unique PUFA 13 production through molecular breeding. 14 15 [
n-6 PUFA biosynthetic pathway (8) (9) (10) . In this strain, most PUFAs are present in 1 triacylglycerols as storage oils, while some are present in phospholipids as structural 2 components of membranes. -methyl-N'-nitro-N-nitrosoguanidine (11) . In addition, a 19 diacylglycerol-accumulating mutant and several lipid-excretive ones have been obtained 20 by the same method. They are valuable not only as producers of useful PUFAs (novel 21 or already existing) but also for providing valuable information on PUFA biosynthesis 22 in this fungus (12). The main features of these mutants are summarized in Table 1 .
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9 Desaturase-defective mutants accumulate stearic acid (18:0) as the main fatty acid 24 5 (up to 40%) in the mycelial oil (13). 12 Desaturase-defective mutants accumulate 1 high levels of n-9 PUFAs, such as Mead acid (MA; 20:3n-9) that are not detected in the 2 wild strain because of a complete deficiency of 12 desaturation (Fig. 1A) . One of 3 these mutants, JT-180, yields a large amount of MA (2.6 g /L, 49% in oil) on 4 commercial production due to its enhanced 5 and 6 desaturase activities, not 5 including n-6 and n-3 PUFAs (14). Double mutants defective in both 12 and 5 6 desaturase activities accumulate n-9 eicosadienoic acid (20:2n-9) as a final product of 7 n-9 PUFAs in large quantities (15). 6 Desaturase-defective mutants accumulate 8 linoleic acid (18:2n-6) as the main fatty acid (up to 32%) in the mycelial oil (16).
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These mutants are characterized by the accumulation of n-6 eicosadienoic acid 10 (20:2n-6) and nonmethylene-interrupted n-6 eicosatrienoic acid (20:3n-65) 11 synthesized from linoleic acid, as shown in Fig. 1B . 5 Desaturase-defective mutants 12 exhibit a high dihomo--linolenic acid (DGLA; 20:3n-6) level (4.1 g/L, 42% in oil) and 13 a reduced concentration (<1%) of AA (17). One of these mutants, S14, is used for the 14 commercial production of DGLA. 3 Desaturase-defective mutants are unable to 15 synthesize n-3 PUFAs at temperatures below 20°C (18), although the wild strain 16 accumulates n-3 PUFAs such as EPA below that temperature. Therefore, these 17 3-desaturase defective mutants are superior to the wild strain for lipid production with 18 a relatively high content of AA. The fatty acid profile of elongase (EL1 for the 19 conversion of palmitic acid, 16:0, to 18:0)-defective mutants is characterized by high 20 levels of 16:0 and palmitoleic acid (16:1n-7), with small amounts of various kinds of 21 n-7 and n-4 PUFAs, as shown in Fig. 1c , which are not detected in the wild strain. The
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total content of these PUFAs in the oil reaches about 30%. In a similar manner, n-1 23 PUFAs can be produced from n-1 hexadecenoic acid (16:1n-1) or 1-hexadecene added 24 6 to the medium (see Fig. 1C ). Triacylglycerols produced by M. alpina 1S-4 account for 1 90% of the total lipids, whereas diacylglycerol-accumulating mutant KY1 derived from 2 the wild strain accumulates 30% diacylglycerols in the total lipids. Lipid-excretive 3 mutant V6 shows the same lipid productivity and fatty acid composition as the wild 4 strain, and excretes 10-40% of the total lipids into the medium during submerged 5 cultivation. Many lipid particles containing triacylglycerols are observed on the 6 surface of V6 mycelia cultivated on a solid medium. V6 is assumed to excrete 7 accumulated lipids out of its mycelia due to its insufficient cell wall structure caused by 8 mutations in the metabolic pathways for cell wall synthesis. below. These nucleotide sequence information revealed mutation sites of the enzymes 14 in the representative mutants as described above (see Table 1 ).
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The three 9 desaturase homologues (designated as 9-1, 9-2, and 9) in M. alpina 16 1S-4 has a cytochrome b 5 -like domain linked to its carboxyl terminus, as also seen for 17 the yeast 9 desaturase (19). Mortierella 9-1 exhibits 45% and 34% amino acid 18 sequence similarity with those of Saccharomyces cerevisiae and rat, suggesting that the 19 Mortierella 9-1 is a membrane-bound protein using acyl-CoA as substrates. Both 20 9-1 and 9-2 desaturate 18:0 to oleic acid (18:1n-9), whereas 9 desaturates a very 21 long saturated fatty acid (26:0) to the corresponding monounsaturated fatty acid
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(26:1n-9) (20). Although the 9-2 gene is not transcribed in the wild strain, the 9-2 23 gene is transcribed and its derivative enzyme exhibits 9 desaturation activities in 9 24 desaturation-defective mutants which have a mutation site in its 9-1 gene.
1 Mortierella 5 and 6 desaturases have a cytochrome b 5 -like domain linked to its 2 N-terminus. The two 6 desaturase homologues (designated as 6-1 and 6-2) are in 3 the wild strain, in which the 6-1 gene is transcribed much more highly (2-to17-fold) 4 than the 6-2 one (21). Mortierella 12 and 3 genes lacking a region encoding a frequency of transformation reached more than 400 transformants/10 8 spores.
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Southern blot analysis revealed that most of the integrated transfer-DNA appeared as a 
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Expression of the gene encoding GLELO, which has been suggested to be the 14 limiting step in AA biosynthesis (32), was successfully performed in M. alpina 1S-4 15 (33). The resulting transformants yielded more AA (3.6 g/l/10 days, 28%) than the 16 wild strain (1.9 g/l/10 days, 19%). In addition, overexpression of the endogenous 17 malce1 gene in M. alpina 1S-4 also led to faster and higher AA accumulation (0.76 g/l/6 18 d, 34%) than in the wild strain 1S-4 (0.68 g/l/6 d, 28%). Overexpression of both 19 malce1 and glelo genes had significant effects on AA production by M. alpina 1S-4.
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The 5 the Pav5 gene in the wild strain led to a high rate of AA and a quite low rate of DGLA 3 in the total fatty acids, compared with AA and DGLA rates in the wild strain. As the 4 same manner, overexpression of the Ost6 gene in the wild strain led to a total higher 5 rate of 18:3n-6, DGLA and AA in the total fatty acid than that in the wild strain 6
Overexpression of the endogenous 3 gene in the wild strain and S14 (5 7 desaturation-defective mutant) led to higher production of EPA (0.8 g/l, 30%) as shown 8 in Fig. 2 and 20:4n-3 (1.8 g/l, 35%), which usually comprise about 10% of the total 9 fatty acids in the wild strain and S14 cultivated at low temperatures (<20°C).
10
Molecular breeding of 3 gene-overexpressing transformants gave only high 11 productivities of these n-3 C20 PUFAs. Overexpression of both the elongase PavElO 12 (involved in the conversion of C20 to C22 PUFAs in marine microalga Pavlova sp.) and
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3 genes in the wild strain led to the formation of C22 PUFAs, n-6 docosatetraenoic 14 acid (22:4n-6) and n-3 docosapentaenoic acid (22:5n-3).
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RNAi method with double strand RNA was applied to silencing gene expression in 16 M. alpina 1S-4 (34) . 12 Gene-silenced strains accumulated n-9 octadecadienoic acid 17 (18:2n-9), 20:2n-9, and MA, which are not detected in either the control strain or 18 wild-type strain 1S-4. The fatty acid composition of these transformants was similar 19 to that of 12 desaturation-defective mutants previously identified. Thus RNAi can be 20 used to alter the types and relative amounts of fatty acids produced by commercial 21 strains of this fungus as a simple method of silencing gene expression.
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The RNAi of the 12 gene in MALCE1 activity-defective mutant M1 led to an 1S-4 (A) and chromatograms of fatty acid methyl esters prepared from fungal cells.
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The strains were cultivated at 12˚C for 11 days. Enhanced activities of 5 and 6 desaturases 7 12 and 5 P166L in (12) 1S-4 and Mut48 b M226-9 20:2n-9 (2.2 g/L, 37%) 15 8 and W301Stop (5) 9
6
Incorrect splicing 1S-4 Mut49 20:3n-6(5) (0.48 g/L, 7%) 16 10
5
Incorrect splicing 1S-4 S14 DGLA (4.1 g/L, 42%) and AA content ( <1%) 17 11
3
W232Stop 1S-4 Y11 AA (1.5 g/L, 45%) without n-3 PUFAs 18 12
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